NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.68. NovaBay Pharmaceuticals shares last traded at $0.65, with a volume of 39,144 shares traded.
NovaBay Pharmaceuticals Stock Down 7.1 %
The company has a market cap of $2.74 million, a P/E ratio of -0.07 and a beta of 2.82.
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Featured Articles
- Five stocks we like better than NovaBay Pharmaceuticals
- What Are the FAANG Stocks and Are They Good Investments?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is the FTSE 100 index?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is the Euro STOXX 50 Index?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
